Qaytona is free while it's in beta — Get started

Ingredients

Vinpocetine

Vinca minor · Ethyl apovincaminate · Cavinton · Apovincaminic acid ethyl ester

Snapshot

IndicationsContraindications
  • Post-stroke disability1
  • Acute cerebral infarction2
  • Cerebral blood flow2, 3
  • Cognitive impairment in dementia4
  • Genetic epilepsy (case reports)5, 6
  • Pregnancy or nursing7
  • Blood-thinning medication use7
  • Low blood pressure7

Vinpocetine is a synthetic ethyl ester of apovincamine, derived from an alkaloid of lesser periwinkle (Vinca minor)8. It raises regional cerebral blood flow and glucose uptake. Supplementation follows from that effect, for memory and cognition and for cerebrovascular disorders such as stroke and dementia9. Typical users are older adults with cognitive decline and stroke survivors. Case reports also describe use in epilepsy linked to gamma-aminobutyric acid (GABA) receptor gene variants5, 6.

A Cochrane review found the evidence in dementia inconclusive and not supportive of clinical use, while an umbrella review of herbal medicines rated cognitive benefit as suggestive4. In acute ischemic stroke, a 2022 meta-analysis of placebo-controlled trials found less death or disability but too little evidence for routine use. A 2021 crossover trial found no cognitive benefit in healthy volunteers or patients with epilepsy10. In a 2026 in vitro study, vinpocetine disrupted development in mouse and human gastruloids at concentrations used for neuroprotective effects; no human trial has tested this. Products are sold mainly as capsules and tablets, with 663 products listing vinpocetine in the NIH label database. A US analysis found some labeled products contained none11.

The developmental findings are the reason behind the pregnancy caution, which US product labels state outright7. For blood-thinning medication or low blood pressure, US product labels ask users to consult a healthcare provider before use7.

Last updated October 16, 2026. Read how we make monographs.

In the full monograph

51 sources, 44 studies

  • When to useThe situations practitioners use it for, each with the reason and the study behind it.
  • SafetyWho should avoid it, who needs extra care, and the side effects reported in studies.
  • InteractionsThe medicines and supplements it interacts with, the effect of each, and what labeling says to watch.
  • Protocol notesThe doses used in studies, how and when they were taken, and how the forms on the market compare.
  • How it worksWhat it is and how it works in the body, in plain terms.
  • Published studiesThe studies behind each use, popular claims checked against them, and trials still under way.
  • Word of mouthWhat patients and practitioners report online, kept separate from the clinical evidence.
  • Clinical perspectiveA closing read of where the evidence is solid, where it is thin, and what has not been studied.

Sources

  1. 1Safety and Efficacy of Vinpocetine as a Neuroprotective Agent in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.pubmed.ncbi.nlm.nih.govPanda, Ramachandran, Panda et al. · Neurocritical care · 2022 · Pubmed
  2. 2Efficacy and Safety of Vinpocetine as Part of Treatment for Acute Cerebral Infarction: A Randomized, Open-Label, Controlled, Multicenter CAVIN (Chinese Assessment for Vinpocetine in Neurology) Trial.pubmed.ncbi.nlm.nih.govZhang, Huang, Li et al. · Clinical drug investigation · 2016 · Pubmed
  3. 3Clinical and non-clinical investigations using positron emission tomography, near infrared spectroscopy and transcranial Doppler methods on the neuroprotective drug vinpocetine: a summary of evidences.pubmed.ncbi.nlm.nih.govVas, Gulyás, Szabó et al. · Journal of the neurological sciences · 2002 · Pubmed
  4. 4Efficacy and safety of herbal medicine on dementia and cognitive function: An umbrella review of systematic reviews and meta-analysis.pubmed.ncbi.nlm.nih.govSawangjit, Chuenchom, Sanverm et al. · Phytotherapy research : PTR · 2023 · Pubmed
  5. 5Vinpocetine improved neuropsychiatric and epileptic outcomes in a patient with a GABRA1 loss-of-function variant.pubmed.ncbi.nlm.nih.govGjerulfsen, Mieszczanek, Johannesen et al. · Annals of clinical and translational neurology · 2023 · Pubmed
  6. 6Personalized medicine: Vinpocetine to reverse effects of GABRB3 mutation.pubmed.ncbi.nlm.nih.govBillakota, Andresen, Gay et al. · Epilepsia · 2019 · Pubmed
  7. 7US product labelsdsld.od.nih.govWarnings printed on US dietary supplement labels with this ingredient, from the NIH Office of Dietary Supplements' Dietary Supplement Label Database (DSLD). Manufacturers' precautions, not evidence of harm
  8. 8Vinpocetine for cognitive impairment and dementia.pubmed.ncbi.nlm.nih.govSzatmari, Whitehouse · The Cochrane database of systematic reviews · 2003 · Pubmed
  9. 9An update on vinpocetine: New discoveries and clinical implications.pubmed.ncbi.nlm.nih.govZhang, Li, Yan · European journal of pharmacology · 2018 · Pubmed
  10. 10Vinpocetine, cognition, and epilepsy.pubmed.ncbi.nlm.nih.govMeador, Leeman-Markowski, Medina et al. · Epilepsy & behavior : E&B · 2021 · Pubmed
  11. 11Identification and quantification of vinpocetine and picamilon in dietary supplements sold in the United States.pubmed.ncbi.nlm.nih.govAvula, Chittiboyina, Sagi et al. · Drug testing and analysis · 2016 · Pubmed